Abstract-Gene set testing has become an indispensable tool for the analysis of high-dimensional genomic data. An important motivation for testing gene sets, rather than individual genomic variables, is to improve statistical power by reducing the number of tested hypotheses. Given the dramatic growth in common gene set collections, however, testing is often performed with nearly as many gene sets as underlying genomic variables. To address the challenge to statistical power posed by large gene set collections, we have developed spectral gene set filtering (SGSF), a novel technique for independent filtering of gene set collections prior to gene set testing. The SGSF method uses as a filter statistic the p-value measuring the statistical significance of the association between each gene set and the sample principal components (PCs), taking into account the significance of the associated eigenvalues. Because this filter statistic is independent of standard gene set test statistics under the null hypothesis but dependent under the alternative, the proportion of enriched gene sets is increased without impacting the type I error rate. As shown using simulated and real gene expression data, the SGSF algorithm accurately filters gene sets unrelated to the experimental outcome resulting in significantly increased gene set testing power.
INTRODUCTION
G ENE set testing has become a critical component in the pipeline used to analyze and interpret high-dimensional genomic data [1] , [2] . Gene set testing enables researchers to step back from the single gene level and explore associations between biologically meaningful groups of genes and clinically relevant variables. A test based on the aggregate effect of a set of functionally related genomic variables offers a number of important benefits relative to individual gene tests including improved statistical power, more intuitive biological interpretation and decreased variability across distinct experimental datasets. The genomic variables of interest typically represent the abundance or variation of nucleic acid molecules associated with specific genes, e.g. expression levels of mRNA molecules, and the variable sets are defined on the basis of common biological function, e.g., all genes whose protein products are active in a specific pathway. Over the past decade, significant progress has been made building and extending gene set collections [3] , [4] , [5] and developing, testing and refining statistical gene set testing methods [6] , [7] , [8] .
One of the primary motivations for gene set testing is to improve statistical power via a reduction in the number of tested hypotheses relative to single gene analysis. The significant growth in gene set collections, however, can often result in gene set testing being performed with nearly as many (and sometimes even more) gene sets than original genomic variables. For example, a version of the gene ontology (GO) [3] loaded on September 16, 2014 into the AmiGO browser [9] has 39,908 non-obsolete terms in the biological process, cellular component and molecular function ontologies with the biological process ontology alone containing 26,501 terms, numbers of gene sets that exceed the number of genes in any relevant experimental organism. Even the much more aggressively filtered molecular signatures database (MSigDB) [5] has grown in size by an order of magnitude between 2005 to 2014 from approximately 1,000 gene sets to over 10,000 with the 4.0 release. The growth in the number of gene sets in these collections is also frequently at the expense of gene set quality with an increasing level of overlap between gene sets and a large proportion of new annotations generated via fully automated methods without any curatorial review or experimental validation. For example, well over 90 percent of all GO annotations have the evidence code IEA (inferred from electronic annotation), meaning the annotation was generated by a computational method such as sequence similarity and has not been reviewed by a human curator [10] . Therefore, not only does gene set testing with large collections fail to deliver an improvement in statistical power, but the decline in annotation quality and higher gene set interdependency can also compromise the biological relevance and interpretability of any associations that are discovered.
The typical approach for addressing the problem of gene set collection size is either to use pre-existing collection subsets, e.g., standard GO Slims [11] or the MSigDB C5 collection that filters out GO terms with IEA evidence codes [5] , or to create custom collection subsets that match a specific use case, e.g., custom GO Slim generation [9] . Although the use of data-independent subsets addresses the issue of collection size and the subsets may closely align with the H.R. Frost domain of investigation, the process of selecting a subset is inherently subjective and thus susceptible to researcher bias. Gene sets not believed to be relevant will not be tested with the result that novel associations may never be found. For hierarchical gene set collections such as GO, methods have also been developed that reduce the number of tested gene sets by using information theoretic measures [12] , [13] or by computing the association for gene sets higher in the hierarchy conditional on the results for child gene sets [14] , [15] , [16] , [17] . Although such GO-specific methods are effective at addressing the significant overlap between GO term annotations, they are specific to hierarchical gene set collections and, for those based on a specific data set, use a criteria for filtering is not independent of the statistic used to test gene set enrichment.
Ideally, the members of a gene set collection subset should be selected based on characteristics of the empirical data under investigation. Such data-driven filtering of hypotheses has been successfully practiced in the context of genomic data analysis at the single gene level [18] , [19] , [20] . In this type of application, a two-stage procedure is followed where, in the first stage, a filter statistic is computed for each genomic variable, e.g., overall variance, and then, in the second stage, the desired statistical analysis is performed on just the set of dependent variables whose filtering statistic passes a given threshold. As detailed by Bourgon et al., such filtering methods can only be successful at improving power in the second stage if the filter statistic is both independent of the second stage test statistic under the null hypothesis (H 0 ) and dependent under the alternative hypothesis (H A ). In other words, if the test statistics follow the null hypothesis distribution, they must be statistically independent of the filter statistics and, if the test statistics follow the alternative hypothesis distribution, the test and filter statistics must be associated. Bourgon et al. refer to filtering methods that meet these requirements as independent filters and the filter statistics as marginally independent filter statistics.
Although data-driven filtering of individual genomic variables has been advocated for gene set testing [21] and empirical methods have been developed to filter out specific annotations [22] , effective independent filters are not currently available that operate on entire gene sets prior to gene set testing. To address both this shortcoming and the challenge posed by large, interdependent and low quality gene set collections, we have developed spectral gene set filtering (SGSF), a novel technique for independent filtering of gene set collections prior to standard gene set testing. The SGSF method uses as a filter statistic the p-value measuring the statistical significance of the association between each gene set and the principal components (PCs) of an empirical data set, taking into account the significance of the eigenvalue associated with each PC. Because this filter statistic is independent of standard gene set enrichment test statistics under H 0 , which we prove in the Appendix, which can be found on the Computer Society Digital Library at http://doi.ieeecomputersociety.org/10.1109/ TCBB.2015.2415815, but dependent under H A , the proportion of significantly enriched gene sets is increased without impacting the type I error rate. Using simulated gene sets with simulated data and MSigDB collections with microarray gene expression data from leukemia and heart failure studies, we show that the SGSF algorithm can significantly increase gene set enrichment power by accurately filtering gene sets unrelated to the experimental outcome.
METHODS

SGSF Inputs
The SGSF method operates over the following three data structures:
1) An n Â p data matrix X quantifying p genomic variables under n experimental conditions. The genomic data held in X, e.g., mRNA expression levels, will be modeled as a sample of n independent observations from a p-dimensional random vector x. It is assumed that any desired transformations on X have been performed and that missing values have been imputed or removed. For the purpose of proving the marginal independence of the spectral gene set enrichment (SGSE) filter (see the Appendix available in the online supplemental material), it is assumed that the distribution of x can be approximated by a multivariate normal distribution (MVNðm m; S SÞ with correlation matrix P). This distributional assumption is often well justified since sources of genomic data, especially gene expression data, typically follow a multivariate normal distribution after appropriate transformations. A generalization to the exponential family of distributions is planned for future work. 2) An n Â 1 vector y of clinical phenotype values measured at each of the n experimental conditions. The phenotype values held in y, e.g., binary case/control status, will be modeled as known constants.
The term "phenotype" should be interpreted quite broadly in this context and simply refers to a experimental variable that is treated as an independent variable in statistical models (see Section 2.2.3). If multiple phenotype variables exist, it is possible to use a matrix Y along with the specification of appropriate parameter contrasts (see, for example, Wu and Smyth [8] ). 3) An f Â p binary annotation matrix A that specifies the annotation of the p genomic variables to f functional categories. The rows of A represent f biological categories, e.g., Kyoto Encyclopedia of Genes and Genomes (KEGG) [4] pathways or GO categories, and the elements a i;j hold indicator variables whose value depends on whether an annotation exists between the function i and genomic variable j.
SGSF Algorithm
The SGSF method identifies a subset of the gene sets defined by A using a non-specific and independent filter based on the statistical significance of the association between each gene set and the spectra of X. Application of the SGSF method in the context of gene set enrichment relative to the variable y involves the following steps, which are illustrated schematically in Figure explained in 
Computation of Filter Statistics Using SGSE
The SGSE method [23] is used to compute the filter statistics, F i , for the gene sets defined by A. Specifically, F i is set to the p-value generated by SGSE for gene set i according to the statistical significance of the association between gene set i and the PCs of X under a competitive null hypothesis. Computation of spectral enrichment p-values by the SGSE method is realized by the following steps as illustrated in Fig. 1a (see Frost et al. [23] for complete details on the SGSE method):
1) Perform PCA on a mean centered and standardized version of X,X. 2) Determine q, the number of PCs used to represent the spectra of X. This can be all PCs with non-zero variance, all PCs that are statistically significant according to the Tracy-Widom test [25] at a specific a level or a fixed number of PCs. For SGSF, the default configuration uses all PCs with non-zero variance.
Although computational more expensive, this option avoids dependence on a subjectively selected a level or specific q value. 3) For all q PCs, use the principal component gene set enrichment (PCGSE) method [26] to compute the statistical significance of the association between each PC and each of the f gene sets defined by A. The PCGSE method computes a p-value for each gene set via two-stage competitive gene set testing in which the correlation between each gene and each PC is used as a gene-level statistic with flexible choice of both the gene set test statistic and the method used to compute the null distribution of the gene set statistic. For SGSF, the default configuration uses the Fishertransformed Pearson correlation coefficient between each gene and each PC as the gene-level test statistic and computes the statistical significance of the association between a gene set and a PC using a correlationadjusted two-sided, two-sample t-test between the gene-level test statistics for genes in the set and the test statistics for genes not in the set. See Frost et al. [26] for complete details on the PCGSE method. 4) Compute the statistical significance of the association between each of the f gene sets and the spectra of X using the weighted Z-method [27] , [28] on the q PCGSE p-values with weights based on the PC variances scaled according to PC statistical significance as quantified by the lower-tailed p-value from the [24] . Takes the phenotype values y, data matrix X and filtered gene set annotation matrix A Ã as inputs and computes the association between each gene set in the filtered collection and the phenotype using a competitive gene set testing method where the gene set test statistics, S k , have a t-distribution under H 0 .
Tracy-Widom test [25] . An important result from the field of random matrix theory (RMT), the TracyWidom law of order 1 distribution describes the variation of a scaled and centered version of the largest eigenvalue of the sample covariance matrix for multivariate normal data under the null model of an identity population covariance matrix (a so-called white Wishart distribution). Using the lower-tailed p-value from the Tracy-Widom test as a weight therefore in the weighted Z-method thus discounts the contribution from all PCs whose eigenvalues are not significantly different from what would be expected under a null model of an identity population covariance matrix. Please see Frost et al. [23] for a more detailed background on the Tracy-Widom distribution and its use in the SGSE method.
Gene Set Collection Filtering
Given filter statistics, F i ; i ¼ 1; . . . ; f, a subset of the gene sets defined by the matrix A of size f Ã < f can be identified using the following steps as illustrated in Fig. 1a: 1) Order the filter statistics from smallest to largest. 2) Select the fÃ gene sets corresponding to the first fÃ filter statistics in the ordered list. The number fÃ can be either a fixed number, e.g., fÃ ¼ :1f, or can be set according to a specified filter statistic threshold a, i.e., fÃ ¼ P f i¼1 1ðF i < aÞ.
3) Generate a matrix A
Ã that contains just the rows of A corresponding to the f Ã gene sets that pass the filter.
Gene Set Testing Using Filtered Gene Sets
It is assumed that testing of the association between each of the fÃ gene sets and the phenotype variable y is performed using a two-stage, competitive gene set testing method, e.g., CAMERA [8] , using the following steps as illustrated in Fig. 1b: 1) Model the relationship between the genomic variables in x and the phenotype y using a series of p univariate linear models of the form
If multiple phenotype variables exist, a contrast of model coefficients must also be specified. Note: if a non-Gaussian exponential family distribution is assumed for x, then a set of generalized linear models would be used instead, however, the current paper considers only the Gaussian case and linear models. 
where m i is the number of genomic variables in set i, z i is the mean of the z j for members of gene set i, z i c is the mean of the z j for genes not in set i and s p is the pooled standard deviation of the z j . CAMERA uses a correlationadjusted version of the mean difference statistic. 4) Determine the statistical significance of the genelevel test statistics under null hypothesis that the z j for genomic variables in the gene set are identically distributed to the z j for genomic variables not in the gene set. CAMERA determines statistical significance using a two-sample t-test on the correlation-adjusted mean difference statistic. Many other two-stage competitive gene set testing methods use permutation of y to calculate a p-value.
SGSF Evaluation 2.3.1 Alternative Gene Set Filtering Methods
To enable a comparative assessment of our SGSF method, two alternative methods for computing the filter statistics, F i , were considered: 1) Set F i to the p-values generated by the SGSE method when executed with weights for the PCGSE p-values in the weighted Z-method set to the PC variance. 2) Set F i to the p-values generated according to a x 2 test of independence of gene set membership relative to variable clusters. Specifically, this method generates p-values by: a) Clustering the p genomic variables inX using kmeans clustering with the Hartigan and Wong algorithm [29] , five restarts and k set according to the global maximum of the gap statistic [30] as computed using the clusGap() function in the cluster R package [31] with the number of bootstrap resamples defaulting to 100. b) Computing the statistical significance of the association between each of the f gene sets defined in A and the k-means clustering using Pearson's x 2 test of independence on a 2 Â k contingency table whose first row holds the counts of gene set members in each of the k clusters and whose second row holds the total size of each of the k clusters.
Evaluation Using Simulated Gene Sets and Simulated Data
The standard SGSF method described in Section 2.2 and both alternative filtering methods outlined in Section 2.3.1 were used to filter gene sets defined by a simulated annotation matrix A using 1,000 simulated data sets each comprised by a matrix X and vector y generated according to the latent component model outlined in Sections 4.1 and 4.2 of Paul et al. [32] . The primary simulation was performed using the following parameter settings:
A was generated as a 60 Â 2;400 matrix defining 60 disjoint gene sets, each of size 40.
X was generated as a 30 Â 2;400 matrix via the model
and z $ N 30 ð0; IÞ. To test the sensitivity of the SGSF method to changes in gene set size, error variance (i.e., s 0 ) and latent factor weights (i.e., l l), simulations were also performed using the following additional six parameter settings. For each of these additional simulations, all parameters were held constant at the values listed above except the indicated parameter:
1)
T : According to all simulation models, the first four simulated gene sets are associated with each of the four latent factors and, consequently, the first four PCs. Only the second latent factor, and, thus, only the second gene set, is associated with y. For the filtering method based on the x 2 test on variable clusters, the number of clusters was fixed at k ¼ 4 rather than estimated using the gap statistic, which should give this method an advantage since k-means will be executed for the exact number of latent factors used to simulated X. The CAMERA method of Wu and Smyth [8] was used to test the statistical association between X and y for the gene sets in A before and after filtering according to a competitive H 0 . The enrichment power for each of the three filtering methods at a range of filter proportions was computed by taking the ratio of the number of truly enriched gene sets to the total number of gene sets with enrichment false discovery rate (FDR) values (as computed using the method of Benjamini and Hochberg [33] ) below .2. The average enrichment power for each filter proportion was computed by simply averaging across all 1,000 simulated data sets.
Evaluation Using Armstrong et al. Leukemia
Gene Expression Data and MSigDB C2 v4.0 Gene Sets
The standard SGSF method and both alternative filtering methods were used to filter the MSigDB C2 v4.0 gene sets for the Armstrong et al. [34] 
RESULTS AND DISCUSSION
Simulation Example
Fig . 2 illustrates the comparative performance of SGSF filtering and the two alternative filtering methods detailed in Section 2.3.1 for the simulation example outlined in Section 2.3.2. As seen in Fig. 2a , when no gene sets are filtered (filter proportion of 0), the behavior of all filtering methods is identical to no filtering and all techniques have an average gene set enrichment power, computed as detailed in Section 2.3.2, of approximately 0:4 across the 1,000 simulated data sets. As the proportion of filtered gene sets increases, average enrichment power quickly drops to near 0 when filtering is based on the Pearson x 2 p-value computed between gene set membership and k-means clusters of the variables. The poor performance of cluster enrichment in this example is due to the inability of k-means clustering to correctly recover the structure of the latent factors. Filtering according to the SGSE p-values computed using PC variance weighting also exhibits a rapid drop in average enrichment performance as the filtering proportion increases. Poor performance in this case is due to the significant impact of lower variance PCs (i.e., PCs unassociated with the four latent factors and representing only noise) on the SGSE computed p-value via the weighted Z-method, as seen in Fig. 2b . In contrast, filtering according to the standard SGSF method (i.e., filter statistics set to SGSE p-values with weights based on the product of PC variance and the lower-tailed Tracy-Widom p-value for the PC variance) is able to achieve average enrichment power that is greater than or equal to that achieved without filtering at all filtering proportions. This is due to the fact that the TracyWidom p-values completely discount contributions from all PCs not associated with the four latent factors, as seen in Fig. 2b . In this simulation example, the best average enrichment for the SGSF method is obtained when 90 percent of the simulated gene sets are filtered.
Results for the other six simulated parameter settings are contained in the Supplemental Material file, available online, and show a similar pattern of superior performance for the SGSF method compared to the alternative methods. These additional simulations demonstrate the robustness of the SGSF method to the tested variations in gene set size, error variance and latent factor weights. Fig. 3 illustrates the significant improvement in gene set enrichment power that is possible when using variancebased filter statistics. Without any filtering, the distribution of gene set enrichment p-values computed via CAMERA relative to the AML versus ALL phenotype is consistent with the null hypothesis, i.e., the p-values are approximately Uð0; 1Þ distributed. Although both alternative filtering methods improve enrichment power, as evidenced by the increase in the relative number of small p-values, their performance is dominated by the standard SGSF method. The specific impact of filtering on enrichment power can be seen in Table 1 , which contains the gene set enrichment FDR q-values for the 25 MSigDB gene sets with the most significant enrichment p-values. Although some of these gene sets, e.g., GOLUB_ALL_VS_AML_DN, are clearly related to the phenotype, without filtering all gene sets appear to have no association after multiple hypothesis correction. The alternative filtering methods represent an improvement on the no filtering case and deliver either one or two biologically plausible gene set associations at an FDR cutoff of .2. For this example, the SGSF method is clearly the most successful at improving enrichment power with 10 out of the top 25 gene sets retained at an FDR level below .2.
Leukemia Gene Expression Example
The SGSF method is effective in this example for two reasons: first, the SGSF filter is independent of the CAMERA gene set enrichment test statistic under H 0 , as proved in Section A and, second, the SGSF filter is associated with the AML versus ALL phenotypes under H A . Marginal independence of the filter statistic enables filtering to increase the relative proportion of significant p-values without increasing the type I error rate. The association between the SGSF filter statistic and the AML versus ALL phenotype, which is nicely illustrated in Fig. 4 of Frost et al. [26] , enables filtering to selectively retain significantly associated gene sets. The The table columns display the gene set enrichment direction, the phenotype enrichment p-value computed via CAMERA, the FDR q-value computed using all tested MSigDB C2 v4.0 gene sets and the FDR q-value computed using each of the tested filtering methods as detailed in Section 2.3.3. If filtering according to a specific method failed to include a specific gene set, the table includes a "-" in place of a q-value.
broader relevance of this class of gene set filters for improving gene set enrichment power in cancer gene expression studies is supported by the finding of Gorlov et al. [37] that genes with large expression variance among cancer cases are more likely to play an important role in tumor-genesis. Fig. 4 The table columns display the gene set enrichment direction, the phenotype enrichment p-value computed via CAMERA, the FDR q-value computed using all tested MSigDB C2 v4.0 gene sets and the FDR q-value computed using each of the tested filtering methods as detailed in Section 2.3.4. If filtering according to a specific method failed to include a specific gene set, the table includes a "-" in place of a q-value.
Carotid Plaque Gene Expression Example
MSigDB gene sets retained by the SGSF method. Although the most significant FDR q-values after SGSF filtering are only slightly below .5, these q-values are supportive of further investigation since they indicate that approximately half of the reported associations at this level are likely true. In fact, seven of the 10 most significant gene sets in Table 2 have reported associations with atherosclerosis. Specifically, for the BHAT_ESR1_TARGETS_VIA_AKT1_DN and BHA-T_ESR1_TARGETS_NOT_VIA_AKT1_DN gene sets, an association has been reported between ESR1 genetic variants and the development of atherosclerotic lesions [38] ; for KEGG_ADHERENS_JUNCTION, there is evidence that junction adherens molecules are involved in atherosclerotic lesion formation through control of endothelial permeability, leukocyte recruitment and platelet deposition [39] , [40] ; for T_INTEGRIN_SIGNALING_PATHWAY, integrin signaling pathways have been implicated in atherosclerotic lesion development via endothelial cell activation [41] ; for BIO-CARTA_TGFB_PATHWAY, TGF-b plays a key role in the development of atherosclerosis via control of the fibroproliferative response to tissue damage [42] ; for PID_ALK2-PATHWAY, the Alk2 signaling pathway is involved endothelial cell activation via interaction with bone morphogenic proteins [43] ; for CARD_MIR302A_TARGETS, miR-302a has been implicated in lipoprotein metabolism and atherosclerosis risk [44] .
CONCLUSION
Gene set testing is a powerful analytical tool that can improve statistical power, biological interpretation and experimental replication. Because of the significant growth in gene set collections, however, the potential gains in statistical power are lost unless some form of gene set filtering is employed. Although the use of predefined collection subsets effectively reduces the number of tested hypotheses, this approach is subjective and vulnerable to researcher bias. Ideally, gene sets collections should be filtered according to statistics of the data under investigation. For such a data-driven filter to successfully improve power, the filter statistic must be marginally independent, i.e., independent of the test statistic under H 0 and dependent under H A . Although independent filters have been identified and successfully utilized for univariate genomic analysis, effective independent filters have not been available that operate on gene sets in the context of gene set testing.
To address this gap, we developed spectral gene set filtering, a novel technique for independent filtering of gene set collections prior to gene set testing. The SGSF method uses as a filter statistic p-values measuring the statistical significance of the association between each gene set and the principal components of an empirical data set, taking into account the significance of the eigenvalue associated with each PC. The SGSF method is effective in any experimental context where the variance structure of genomic variables is associated with the experimental outcome of interest under the alternative hypothesis. Because this filter statistic is independent of standard gene set enrichment test statistics under H 0 , the proportion of significantly enriched gene sets is increased without impacting the type I error rate. As shown using simulated gene sets with simulated data and MSigDB collections with microarray gene expression data, the SGSF algorithm accurately filters gene sets unrelated to the experimental outcome resulting in significantly increased gene set enrichment power.
Limitations of the SGSF method include the dependence on a multivariate normal distribution for the genomic data to prove the marginal independence of the filter statistic and, importantly, the requirement for power improvement that the gene sets enriched within the variance structure of the data, as detected by the SGSE method, are also associated with the clinical outcome under the alternative hypothesis. Although this later requirement has been found to hold well for cancer gene expression data [37] , further testing with different clinical endpoints and different types of genomic data will be essential to determine the generality of the SGSF approach.
AVAILABILITY
The MSigDB C2 v4.0 gene sets can be downloaded from http://www.broadinstitute.org/gsea/msigdb/collections. jsp. The Armstrong et al. [34] leukemia gene expression data can be downloaded from http://www.broadinstitute.org/ gsea/datasets.jsp. The BiKE carotid plaque gene expression data [35] can be downloaded from GEO at http://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21545. An implementation of the SGSE algorithm used to compute the SGSF filter statistic is available in the PCGSE R package (version ! 0:2, http://cran.r-project.org/web/packages/ PCGSE/index.html). Due to the dependency on the Bioconductor package safe, it is recommended that PCGSE be installed using the biocLite() function. At the R prompt, enter:
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